For the love of Imugene....
Patience everyone. Paul Hopper's first sale in 8 years gave the market makers and retail a big red button labelled SELL.
Does that mean everyone should panic?
"why is the share price going down?"
"why wasn't yesterday's announcement enough to get it to all time highs?"
Blah blah blah.
Market is waiting for results not speculation on drugs/combinations not yet in the clinic... I'm not saying they aren't significant milestones, I'm excited as most of you are but I too am waiting for results.
Look at the forgotten child MSB at the moment. Abandoned by Novartis and smashed 16% as we speak, meanwhile at Imugene HQ we are going to be running alongside the biggest drug in the market Keytruda (at $14 billion US sales a year).
Key points:
1) market never likes Directors selling
2) we haven't had a bad announcement/results
3) business as usual
4) remind yourself of what Imugene working towards with a lot of hot irons in the fire.
(20min delay)